Bacteriological failure · Adults and children with cholera diarrhoea
Azithromycin may leads to lower bacteriological failure compared with ciprofloxacin (low certainty).
1 finding from 1 review
Duration of diarrhoea · Adults and children with cholera diarrhoea
1 finding from 1 review
Microbiological efficacy ‐ pathogen eradication · patients with chronic bacterial prostatitis
It is very uncertain whether levofloxacin changes microbiological efficacy ‐ pathogen eradication compared with ciprofloxacin (very low certainty).
1 finding from 1 review
Clinical efficacy ‐ cure or improvement at · patients with chronic bacterial prostatitis
It is very uncertain whether ciprofloxacin changes clinical efficacy ‐ cure or improvement at end of treatment compared with comparator fluoroquinolone (very low certainty).
2 findings from 1 review
Adverse effects of treatment ‐ any adverse effects · patients with chronic bacterial prostatitis
Ciprofloxacin showed no clear difference in adverse effects of treatment ‐ any adverse effects compared with comparator fluoroquinolone (moderate certainty).
1 finding from 1 review
Microbiological efficacy ‐ pathogen eradication · patients with chronic bacterial prostatitis
It is very uncertain whether levofloxacin changes microbiological efficacy ‐ pathogen eradication compared with comparator fluoroquinolone (very low certainty).
1 finding from 1 review
Clinical efficacy ‐ cure or improvement at · patients with chronic bacterial prostatitis
2 findings from 1 review
Adverse effects of treatment ‐ any adverse effects · patients with chronic bacterial prostatitis
Levofloxacin showed no clear difference in adverse effects of treatment ‐ any adverse effects compared with comparator fluoroquinolone (moderate certainty).
1 finding from 1 review
Clinical efficacy ‐ cure or improvement at · patients with chronic bacterial prostatitis
Levofloxacin showed no clear difference in clinical efficacy ‐ cure or improvement at end of treatment compared with ciprofloxacin (low certainty).
2 findings from 1 review
Adverse effects of treatment ‐ any adverse effects · patients with chronic bacterial prostatitis
Levofloxacin showed no clear difference in adverse effects of treatment ‐ any adverse effects compared with ciprofloxacin (moderate certainty).
1 finding from 1 review
Microbiological efficacy ‐ pathogen eradication · patients with chronic bacterial prostatitis
Lomefloxacin showed no clear difference in microbiological efficacy ‐ pathogen eradication at compared with comparator fluoroquinolone (low certainty).
1 finding from 1 review
Clinical efficacy ‐ cure or improvement at · patients with chronic bacterial prostatitis
2 findings from 1 review
Adverse effects of treatment ‐ any adverse effects · patients with chronic bacterial prostatitis
Lomefloxacin showed no clear difference in adverse effects of treatment ‐ any adverse effects compared with comparator fluoroquinolone (moderate certainty).
1 finding from 1 review
Microbiological efficacy ‐ pathogen eradication · patients with chronic bacterial prostatitis
It is very uncertain whether ciprofloxacin changes microbiological efficacy ‐ pathogen eradication at end of treatment compared with comparator fluoroquinolone (very low certainty).
1 finding from 1 review
Duration of diarrhoea · patients symptomatic for NTS infection
1 finding from 1 review
Fever clearance time · patients symptomatic for NTS infection
1 finding from 1 review
Duration of illness · patients symptomatic for NTS infection
1 finding from 1 review
Clinical treatment failure (Persistent or worsening symptoms at the end of treatment) · patients symptomatic for NTS infection
It is very uncertain whether antibiotics changes clinical treatment failure (Persistent or worsening symptoms at the… compared with placebo or no treatment (very low certainty).
1 finding from 1 review
Diarrhoea · patients symptomatic for NTS infection
It is very uncertain whether antibiotics changes presence of diarrhoea at 2‐4 days compared with placebo or no treatment (very low certainty).
2 findings from 1 review